Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 2, 2013, Pages 247-254

  Srivastava, Priyanka ^a   Kapoor, Rakesh ^a   Mittal, Rama D ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bacillus Calmette Guerin; Bladder cancer; Haplotypes; Matrix metalloproteinase; Polymorphism; Recurrence free survival

Indexed keywords

ADULT; ALLELE; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 8 GENE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

CARCINOMA, TRANSITIONAL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84875274883     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.01.001     Document Type: Article

References (26)

1. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000, 10:415-433.
2. Bodey B., Bodey B., Siegel S.E., et al. Matrix metalloproteinase expression in malignant melanomas: Tumor-extracellular matrix interactions in invasion and metastasis. In Vivo 2001, 15:57-64.
3. Price S.J., Greaves D.R., Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: Role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001, 276:7549-7558.
4. Balbín M., Fueyo A., Tester A.M., et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003, 35:252-257.
5. Montel V., Kleeman J., Agarwal D., et al. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res 2004, 64:1687-1694.
6. Srivastava P., Gangwar R., Kapoor R., et al. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers 2010, 29:37-46.
7. Srivastava P., Mandhani A., Kapoor R., et al. Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort. Ann Surg Oncol 2010, 17:3068-3075.
8. Colombel M., Soloway M., Akaza H. Epidemiology, staging, grading and risk stratification of bladder cancer. Eur Urol Suppl 2008, 7:618-626.
9. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
10. Delgado-Enciso I., Cepeda-Lopez F.R., Monrroy-Guizar E.A., et al. Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 2008, 65:68-72.
11. Li Y., Sun D.L., Duan Y.N., et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 2010, 37:197-205.
12. Qiu W., Zhou G., Zhai Y., et al. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomarkers Prev 2008, 17:2514-2518.
13. Ye S. Polymorphism in matrix metalloproteinase gene promoters: Implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000, 19:623-629.
14. Hu Z., Huo X., Lu D., et al. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 2005, 11:5433-5439.
15. Vasku A., Goldbergová M., Hollá L.I., et al. Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure. Clin Chem Lab Med 2003, 41:1299-1303.
16. Cotignola J., Roy P., Patel A., et al. Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression. J Negat Results Biomed 2007, 6:9.
17. Zhou Y., Yu C., Miao X., et al. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 2004, 25:399-404.
18. Yu C., Pan K., Xing D., et al. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 2002, 62:6430-6433.
19. Miao X., Yu C., Tan W., et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003, 63:3987-3990.
20. Xu E.P., Huang Q., Lu B.J., et al. The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:78-81.
21. Lin S.C., Lo S.S., Liu C.J., et al. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004, 33:405-409.
22. Elander N., Söderkvist P., Fransén K. Matrix metalloproteinase (MMP) -1, -2, -3, and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 2006, 26:791-795.
23. Roehe A.V., Frazzon A.P., Agnes G., et al. Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: Preliminary results. Breast Cancer Res Treat 2007, 102:123-124.
24. Grieu F., Li W.Q., Iacopetta B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 2004, 88:197-204.
25. González-Arriaga P., López-Cima M.F. Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. BMC Cancer 2008, 8:378.
26. Decock J., Long J.R., Laxton R.C., et al. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 2007, 67. 1021-21.